Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Muscarinic cholinergic binding sites on rat lymphocytes.

Authors
Costa-LG; Kaylor-G; Murphy-SD
Source
Immunopharmacology 1988 Nov-Dec; 16(3):139-149
NIOSHTIC No.
00190447
Abstract
A more comprehensive pharmacological characterization was sought of muscarinic cholinergic binding sites in rat lymphocytes. Male Sprague-Dawley-rats were used for the isolation of spleen lymphocytes on a histopaque gradient. The lymphocytes were then incubated in Hank's buffer with tritium labeled quinuclidinyl- benzilate (3H-QNB). The binding of 3H-QNB was linear with increasing protein concentrations and was saturable. Several cholinergic muscarinic drugs were able to inhibit 3H-QNB, as determined through an extensive pharmacological analysis of the binding sites. Muscarinic antagonists were more potent than agonists. Lipophilic drugs were more potent than hydrophilic drugs. 3H-QNB binding was also inhibited by several noncholinergic drugs. These drugs behaved similarly in rat brain membranes, while a third group of noncholinergic drugs and neurotransmitters remained inactive. Circulating lymphocytes and lymphocyte membranes from rats gave the same results. The authors suggest that lymphocytes possess muscarinic receptors which share several, but not all, of the characteristics of the same receptors in brain and other tissues. The status of the muscarinic receptors in solid tissues can be monitored by measuring these binding sites.
Keywords
NIOSH-Publication; NIOSH-Grant; Grants-other; Laboratory-animals; Blood-cells; Drug-interaction; Neurotransmitters; Cholinergic-receptors; In-vitro-studies
Contact
Environmental Health University of Washington Dept of Environ Hlth, SC-34 Seattle, WA 98195
CODEN
IMMUDP
Publication Date
19881101
Document Type
Journal Article
Funding Amount
97100.00
Funding Type
Grant
Fiscal Year
1989
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-K01-OH-00054
Issue of Publication
3
ISSN
0162-3109
Priority Area
Other Occupational Concerns; Grants-other
Source Name
Immunopharmacology
State
ME; WA
Performing Organization
University of Washington, Seattle, Washington
TOP